Argentina approves accession to the PCT and moves towards a new route for protecting inventions in the country

This post is also available in: Spanish

Yesterday, Argentina took the decisive step towards joining the PCT: the Senate approved the country’s accession to the Patent Cooperation Treaty.

Argentina, which was the only G20 country that was not yet a party to the Treaty, must now deposit its instrument of accession with the World Intellectual Property Organization (WIPO). The PCT will enter into force for Argentina three months after the date of that deposit.

Once this process has been completed, what will change for innovative organisations?

Until now, foreign applicants wishing to obtain patent protection in Argentina had to file a patent application directly in the country within the 12-month priority period. Once the Treaty enters into force, applicants will also be able to seek protection in Argentina through the PCT route, deferring the decision to enter the Argentine national phase until 30 months from the priority date.

This additional time will allow organisations to make a more informed assessment of Argentina’s commercial potential, a market of more than 46 million people and Latin America’s third-largest economy. They will also be able to consider how the technology evolves and whether the investment required to enter the national phase is commercially justified.

Foreign patent applications in Argentina

According to WIPO data, 2,872 patent applications of foreign origin were filed with the Argentine patent office in 2025. The United States ranked first by a wide margin, with 1,140 applications, followed by Switzerland (238), Germany (205) and China (144). The United Kingdom, France, the Netherlands and Japan also featured prominently.

Applications originating in Spain increased from 36 in 2024 to 49 in 2025, representing growth of 36% in one year.

Argentina’s accession to the PCT can be expected to increase the number of foreign-origin patent applications filed in the country.

Beyond the number of applications, however, the change will enable innovative organisations to coordinate the protection of their inventions more effectively in the largest country in the Southern Cone and align it with other strategic decisions, including investment, potential licensing agreements and the commercial viability of entering the Argentine market.

Tomás Llamas
Tomás joined ABG in 2007 and is a partner in the chemistry, and materials, and pharma department. His practice is focused on patent prosecution and opinion work in the area of organic chemistry. He is a qualified European Patent Attorney (EQE, 2012). Before he joined ABG, Tomás completed his doctoral thesis on asymmetric synthesis at the Universidad Autónoma de Madrid (2003-2007), including a pre-doctoral stay at Scripps Research Institute (San Diego, EEUU) focusing on total synthesis of natural products, and was a post-doctoral fellow for Spanish chemical company Fyse-Ercos S.A. (2006-07), working on Medical Chemistry.
Tomás Llamas on EmailTomás Llamas on Linkedin

Share this post with interested parties

Subscribe to our newsletter

Next Events

No event found!